
New Lantern is an AI-powered medical imaging platform designed to enhance radiologists' efficiency and diagnostic confidence. Its key products include an AI Radiology Resident named Curie, a smart worklist for case distribution, a cloud-native PACS viewer, and an AI Reporter that automates 75% of radiology reports, saving over 100 minutes per shift. The platform integrates AI measurements, free dictation, segmentation infrastructure, and document AI for auto-filling reports. Trusted by leading radiologists and healthcare providers, New Lantern offers lightning-fast implementation, cost savings through cloud-native PACS, and personalized impressions tailored to clinical contexts, positioning it as a transformative solution in radiology workflows.

New Lantern is an AI-powered medical imaging platform designed to enhance radiologists' efficiency and diagnostic confidence. Its key products include an AI Radiology Resident named Curie, a smart worklist for case distribution, a cloud-native PACS viewer, and an AI Reporter that automates 75% of radiology reports, saving over 100 minutes per shift. The platform integrates AI measurements, free dictation, segmentation infrastructure, and document AI for auto-filling reports. Trusted by leading radiologists and healthcare providers, New Lantern offers lightning-fast implementation, cost savings through cloud-native PACS, and personalized impressions tailored to clinical contexts, positioning it as a transformative solution in radiology workflows.
Product: AI-powered medical imaging platform (Curie AI Radiology Resident, AI Reporter, cloud-native PACS, smart worklist)
Value: Automates radiology tasks and reporting (claims ~75% report automation, saves 100+ minutes per shift)
Founded / HQ: Founded 2021; headquartered in San Francisco, California
Team size: Approximately 16 employees
Funding: Raised $19M Series A (Nov 20, 2024); total funding reported $22.6M
Radiology workflow automation and medical imaging software
2021
Healthtech / Medical imaging
19000000.00
“Syndicate includes Benchmark as lead; investors reported across rounds include SV Angel, Saji Wickramasekara, Neo, Menlo Ventures, Henry Shi, Guillermo Rauch, Gokul Rajaram, Amjad Masad, and Afore Capital”